학술논문

Analgesic use and circulating estrogens, androgens, and their metabolites in the Women's Health Initiative Observational Study
Document Type
article
Source
Cancer Prevention Research. 15(3)
Subject
Cancer
Clinical Research
Estrogen
Aging
Prevention
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Analgesics
Androgens
Anti-Inflammatory Agents
Non-Steroidal
Aspirin
Estradiol
Estrogens
Female
Humans
Male
Postmenopause
Women's Health
Clinical Sciences
Oncology and Carcinogenesis
Oncology & Carcinogenesis
Language
Abstract
Though studies have observed inverse associations between use of analgesics (aspirin, NSAIDs, and acetaminophen) and the risk of several cancers, the potential biological mechanisms underlying these associations are unclear. We investigated the relationship between analgesic use and serum concentrations of estrogens, androgens, and their metabolites among postmenopausal women to provide insights on whether analgesic use might influence endogenous hormone levels, which could in turn influence hormone-related cancer risk. The study included 1,860 postmenopausal women from two case-control studies nested within the Women's Health Initiative Observational Study. Analgesic use was reported at study baseline. Fifteen estrogens and estrogen metabolites and 12 androgens and androgen metabolites were quantified in baseline serum by LC/MS-MS. Linear regression with inverse probability weighting, stratified by menopausal hormone therapy (MHT) use, was used to estimate adjusted geometric mean concentrations of each hormone by analgesic use. Among women not currently using MHT (n = 951), low-dose aspirin (